Metals such as platinum, gold, ruthenium, titanium and tin can be a source of biologically active derivatives and, occasionally, become tools in the chemotherapy against different kinds of human tumors. The preclinical evaluation includes not only antitumor activity tests but also the investigation of the particular chemistry, the molecular targets within biological materials and the effect on the survival of a cell within its particular environment.
These metals may form coordination compounds by binding ligands firmly or loosely, depending on the chemical nature of both the metal ion and the ligands. A loosely coordinated chloride ion or water molecule will exchange for a more nucleophilic biomolecule, commonly a nucleobase or a sulfur-containing amino acid side chain, and thereby infer a biological lesion. A metal ion complex may require an exchange of one or more ligands for water in order to become activated. All the firmly bound, conserved, ligands influence both target selection and reactivity of the metal ion. Following the important thesis of Collier and Krauss from the 30s ("The effect of a heavy metal on experimental murine cancer is not only due to the metal alone, but also to the structure of the compounds and the type of compound"), it should be emphasized that the efficacy of a metal complex against cancer is primarily related to the kind of its set of ligands and to the resulting substitution stability of the different bounded ligands. Under this aspect, two new tumor-inhibiting metal complexes will be discussed in this article, the ruthenium complex trans-lndazole-tetrachlorobis(indazole)ruthenate(lll) and the titanium complex Budotitane (INN), cis-dlethoxybis(1-phenylbutane-1,3-dionato)titanium(IV) (Fig. 1) (between n = 2 and n 3) could be confirmed by vapour pressure osmometric measurements. The much higher decomposition rate of budotitane has consequences for the galenic formulation of the complex. A drug used in the clinic or in preclinical toxicological and pharmacological studies must be relatively insensitive to hydrolysis; if it is not, a galenic formulation must guarantee these properties. In the case of budotitane, the use of CremophorEL, a glycerinepolyethyleneglycolericinoleate (BASF), is successful. Budotitane, CremophorEL and propylenglycole are dissolved in water-free ethanol (weight ratio 1 9 1), the evaporated product is known as a coprecipitate. In order to examine the decomposition of the complex in the watery micellar emulsion, UV-spectra were taken and the levels of intact complex were calculated by component analysis. Fig.6 shows that the major amount (80%) of the micellar emulsion, after a rapid decomposition of 20% of the titanium complex, is stable over many hours in the region from 1 to 2 percent coprecipitate by weight in phys. saline. The initial rapid decomposition must probably be attributed to the destruction of micelles that were defective from the start. (10 mM NaCI, Salmon Testes DNA)
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